Rate My Professor Simone Schueller

Schueller’s research specializations encompass immunomodulation for preventive and therapeutic strategies in neonates and comparative immune ontogeny in neonates and adults to inform vaccine adjuvant development. She has earned notable awards, including the Paediatric Research Early Career Investigator Award in 2017 and the Max Kade Research Fellowship by the Austrian Academy of Science in 2016. Key publications include “Intravenous pentoxifylline is well tolerated in critically ill preterm infants with sepsis or necrotizing enterocolitis” (2020, European Journal of Pediatrics, with Kempf, K., Unterasinger, L., Strunk, T., Berger, A.), “Immunomodulation to prevent or treat neonatal sepsis: Past, present, and future” (2018, Frontiers in Pediatrics, with Kramer, B. W., Villamor, E., Spittler, A., Berger, A., Levy, O.), “Review demonstrates that less invasive surfactant administration in preterm neonates leads to fewer complications” (2018, Acta Paediatrica, with Gortner, L., Herting, E.), “Acute Respiratory Distress in a Child with H3N2 Infection” (2018, Klinische Padiatrie), and “Safety and Efficacy of Micafungin in Extremely Low Birth Weight Infants” (2018, The Pediatric Infectious Disease Journal, with Bauer, C., Unterasinger, L., Berger, A.). Her scholarly impact is reflected in an h-index of 9 and 250 citations.